EurekAlert! News by Subject: Medicine & Health

Medicine & Health

Updates every hour. Last Updated: 8-May-2026 16:17 ET (8-May-2026 20:17 GMT/UTC)

18-Nov-2025

Insilico Medicine’s CEO Dr. Alex Zhavoronkov recognized among global top one per cent for pharmacology and toxicology

InSilico Medicine
Grant and Award Announcement

Following previous honors in 2022 and 2024, this recognition highlights Dr. Zhavoronkov’s exceptional and sustained research influence, which forms the scientific foundation of Insilico’s end-to-end generative AI platform, Pharma.AI, and the company’s diverse AI-driven drug discovery pipeline.

18-Nov-2025

How growth hormone excess accelerates liver aging via glycation stress

Impact Journals LLC
Peer-Reviewed Publication

BUFFALO, NY — November 18, 2025 — A new research paper was published in Volume 17, Issue 10 of Aging-US on October 3, 2025, titled “Growth hormone excess drives liver aging via increased glycation stress.”

Journal: Aging-US

18-Nov-2025

$3.7 million in NIH funding for research into sand flies, vectors of parasitic disease leishmaniasis, goes to UNC Greensboro

University of North Carolina at Greensboro
Grant and Award Announcement

Professor Gideon Wasserberg at UNC Greensboro has been awarded a prestigious $3.7 million National Institutes of Health R01 grant to advance his research on controlling sand flies, the vectors of the parasitic disease leishmaniasis. Leishmaniasis affects more than 1 million people each year and is found in approximately 90 countries in tropical and arid regions of the world, putting approximately 1 billion people at risk.

18-Nov-2025

Starting opioid agonist treatment after hospitalization for toxicity halves risk of repeat event

University of Toronto - Leslie Dan Faculty of Pharmacy
Peer-Reviewed Publication

Almost one quarter of hospital-treated opioid toxicities in Ontario experienced a repeat event within six months, but early initiation of opioid agonist therapy (OAT) can cut that risk almost in half.

Journal: BMJ Public Health

18-Nov-2025

Muscle protein linked to exercise opens new way to treat Alzheimer’s

Florida Atlantic University
Peer-Reviewed Publication

A study unveils a novel strategy to combat Alzheimer’s disease (AD) by targeting muscle health. Researchers found that skeletal muscles, through the protein Cathepsin B (Ctsb) released during exercise, can protect cognitive function. In AD-model mice, boosting muscle Ctsb improved memory and motor skills, even without reducing classic brain plaques. The treatment promoted hippocampal cell growth and restored critical protein balance, revealing a powerful muscle-brain connection. This work suggests exercise, gene therapy or drugs that enhance muscle Ctsb could offer a promising new avenue against cognitive decline.

Journal: Aging Cell

18-Nov-2025

AASM congratulates Sleep Medicine Disruptors Innovation Award winners

American Academy of Sleep Medicine
Business Announcement

The American Academy of Sleep Medicine congratulates Bairitone Health and Noctrix Health, whose innovations were selected as the people’s choice winners of the first AASM Sleep Medicine Disruptors Innovation Award. The votes were cast by attendees of Sleep Medicine Disruptors 2025, which was held in person in Austin, Texas, and livestreamed Nov. 14 - 15.

18-Nov-2025

Thinking takes energy

Bielefeld University
Peer-Reviewed Publication

Thinking requires energy: a new study shows how our brain metabolism sets the limits of thinking. Researchers explain why cognitive models remain incomplete without considering biological resources.

Journal: Behavioral and Brain Sciences

18-Nov-2025

First-of-its kind nationwide telehealth therapeutic clinical trial for cancer now open at Ohio State

Ohio State University Wexner Medical Center
Business Announcement

A promising new targeted cancer therapy is now available to certain patients with advanced pancreatic cancer – from the comfort of their home. The treatment is available through a first-of-its-kind, entirely telehealth-based targeted cancer drug therapy nationwide clinical trial led by The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC – James).

Funder: Gateway for Cancer Research

18-Nov-2025

ARC at Sheba Medical Center and Mount Sinai launch collaboration with NVIDIA to crack the hidden code of the human genome through AI

The Mount Sinai Hospital / Mount Sinai School of Medicine
Business Announcement

ARC Innovation at Sheba Medical Center and Icahn School of Medicine at Mount Sinai (part of the Mount Sinai Health System in New York City) today announced a landmark three-year collaboration with NVIDIA to harness the power of artificial intelligence for genomic discovery through the application of large language model (LLM) technology. The initiative aims to pioneer the decoding of the majority of the human genome that remains poorly understood in order to unlock new pathways for disease prevention, diagnosis, and treatment. Over the three-year period, the project will be supported by significant investment from the participating organizations, with the goal of accelerating research that can ultimately benefit patients worldwide.